HSF advises on the acquisition of a majority stake in BTSA
Herbert Smith Freehills (HSF) has advised Abac Capital on the acquisition, through an investment vehicle, of a majority stake in BTSA Biotecnologías Aplicadas and its US subsidiary.
BTSA Biotecnologías Aplicadas is a global company headquartered in Spain, with commercial offices in the United States and Mexico. With more than 25 years of experience, the firm specialises in the manufacture of natural antioxidants and natural vitamin E for the food, cosmetics, healthcare, pharmaceutical and animal nutrition industries.
The team from HSF advising Abac Capital was formed by the partner, Nicolás Martín (pictured), the associate, Ignacio Segura and the lawyers, Alejandro Grima Margarit, Carmen Muñoz Miranda, Cristina Diez de Rivera and Carmen Jara.
